[1] |
Banas JA. Virulence properties of Streptococcus mutans[J]. Front Biosci,2004(9):1267-1277.
|
[2] |
凌均棨.变形链球菌感受态形成的基因调控网络[J].中华口腔医学杂志,2015,50(6):342-345.
|
[3] |
Bugg TD, Braddick D, Dowson CG,et al. Bacterial cell wall assembly:still an attractive antibacterial target[J]. Trends Biotechnol,2011,29(4):167-173.
|
[4] |
Barreteau H, Kovac A, Boniface A,et al. Cytoplasmic steps of peptidoglycan biosynthesis[J]. FEMS Microbiol Rev,2008,32(2):168-207.
|
[5] |
Cava F, Lam H, de Pedro MA,et al. Emerging knowledge of regulatory rols of D-amino acids in bacteria[J]. Cell Mol Life Sci,2011,68(5):817-813.
|
[6] |
Ayengar P, Roberts E. Utilization of D-glutamic acid by Lactobacillus arabinosus:glutamic racemase[J]. J Biol Chem,1952,197(1):453-460.
|
[7] |
Balikó G, Venetianer P. An Escherichia coli gene in search of a function:phenotypic effects of the gene recently identified as murI[J]. J Bacteriol,1993,175(20):6571-6577.
|
[8] |
Lundqvist T, Fisher SL, Kern G,et al. Exploitation of structural and regulatory diversity in glutamate racemases[J]. Nature,2007,447(7146):817-822.
|
[9] |
Kim KH, Bong YJ, Park JK,et al. Structural basis for glutamate racemase inhibition[J]. J Mol Biol,2007,372(2):434-443.
|
[10] |
Kim WC, Rhee HI, Park BK,et al. Isolation of peptide ligands that inhibit glutamate racemase activity from a random phage display library[J]. J Biomol Screen,2000,5(6):435-440.
|
[11] |
Kimura K, Tran LS, Itoh Y. Roles and regulation of the glutamate racemase isogenes,racE and yrpC,in Bacillus subtilis[J]. Microbiology,2004,150(Pt 9):2911-2920.
|
[12] |
Sengupta S, Nagaraja V. Inhibition of DNA gyrase activity by Mycobacterium smegmatis MurI[J]. FEMS Microbiol Lett,2008,279(1):40-47.
|
[13] |
Fisher SL. Glutamate racemase as a target for drug discovery[J]. Microbial Biotechnology,2008,1(5):345-360.
|
[14] |
Pucci MJ, Thanassi JA, Ho HT,et al. Staphylococcus haemolyticus contains two D-glutamic acid biosynthetic activities,a glutamate racemase and a D-amino acid transaminase[J]. J Bacteriol,1995,177(2):336-342.
|
[15] |
de Jonge BL, Kutschke A, Newman JV,et al. Pyridodiazepine amines are selective therapeutic agents for Helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy[J]. Antimicrob Agents Chemother,2015,59(4):2337-2342.
|
[16] |
Gallo KA, Knowles J. Purification,cloning,and cofactor independence of glutamate racemase from Lactobacillus[J]. Biochemistry,1993,32(15):3981-3990.
|
[17] |
Nakajima N, Tanizawa K, Tanaka H,et al. Cloning and expression in Escherichia coli of the glutamate racemase gene from Pediococcus pentosaceus[J]. Agric Biol Chem,1986,50(11):2823-2830.
|
[18] |
Bhagavan NV. Medical biochemistry. Chapter 6:Enzymes I:General Properties,Kinetics,and Inhibition[M]. 4th ed. Academic Press,2001:85-108.
|
[19] |
Ashiuchi M, Yoshimura T, Esaki N,et al. Inactivation of glutamate racemase of Pediococcus pentosaceus with L-serine-O-sulfate[J]. Biosci Biotech Biochem,1993,57(11):1978-1979.
|
[20] |
Glavas S, Tanner ME. The inhibition of glutamate racemase by D-N-hydroxylglutamate[J]. Bioorg Med Chem Let,1997,7(17):2265-2270.
|
[21] |
Tanner ME, Miao S. The synthesis and stability of aziridino-glutamate,an irreversible inhibitor of glutamate racemase[J]. Tet Let,1994,35(24):4073-4076.
|
[22] |
de Jonge BL, Kutschke A, Uria-Nickelsen M,et al. Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase(MurI)[J]. Antimicrob Agents Chemother,2009,53(8):3331-3336.
|
[23] |
Choi SY, Esaki N, Ashiuchi M,et al. Bacterial glutamate racemase has high sequence similarity with myoglobins and forms an equimolar inactive complex with hemin[J]. Proc Natl Acad Sci USA,1994,91(21):10144-10147.
|
[24] |
Corrigan RM, Abbott JC, Burhenne H,et al. c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress[J]. PLoS Pathog,2011,7(9):e1002217.
|
[25] |
Doublet P, van Heijenoort J, Bohin JP,et al. The murI gene of Escherichia coli is an essential gene that encodes a glutamate racemase activity[J]. J Bacteriol,1993,175(10):2970-2979.
|
[26] |
Morayya S, Awasthy D, Yadav R,et al. Revisiting the essentiality of glutamate racemase in Mycobacterium tuberculosis[J]. Gene,2015,555(2):269-276.
|
[27] |
Li Y, Mortuza R, Milligan DL,et al. Investigation of the essentiality of glutamate racemase in Mycobacterium smegmatis[J]. J Bacteriol,2014,196(24):4239-4244.
|
[28] |
Oh SY, Richter SG, Missiakas DM,et al. Glutamate racemase mutants of Bacillus anthracis[J]. J Bacteriol,2015,197(11):1854-1861.
|
[29] |
Zhang J, Liu J, Ling J,et al. Inactivation of glutamate racemase(MurI)eliminates virulence in Streptococcus mutans[J]. Microbiol Res,2016(186-187):1-8.
|
[30] |
樊明文.牙体牙髓病学[M]. 4版.北京:人民卫生出版社,2012:18.
|